Evidence map›Paper›PMID 40005637›Full record

ArticleMicroorganisms2025

Evaluation of the Anti-Mycobacterial and Anti-Inflammatory Activities of the New Cardiotonic Steroid γ-Benzylidene Digoxin-15 in Macrophage Models of Infection.

Daniel Wilson A Magalhães, Maria Gabriella S Sidrônio, Noêmia N A Nogueira, Deyse Cristina Madruga Carvalho, Maria Eugênia G de Freitas, Ericke Cardoso Oliveira, Gustavo F de Frazao Lima, Demétrius A M de Araújo, Cristoforo Scavone, Thalisson Amorim de Souza and 5 more

Abstract read
In one paragraph

Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Integrative transcriptome-based drug repurposing in tuberculosis.bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Daniel Wilson A MagalhãesPostgraduate Program in Physiological Sciences, Federal University of Paraíba (UFPB), João Pessoa 58051-900, PB, Brazil.ORCID 0000-0003-2198-1867
Maria Gabriella S SidrônioPostgraduate Program in Development and Technological Innovation in Medicines, Federal University of Paraíba (UFPB), João Pessoa 58051-900, PB, Brazil.
Noêmia N A NogueiraPostgraduate Program in Physiological Sciences, Federal University of Paraíba (UFPB), João Pessoa 58051-900, PB, Brazil.
Deyse Cristina Madruga CarvalhoLaboratory of Immunobiotechnology, Biotechnology Center, Federal University of Paraíba (UFPB), João Pessoa 58051-900, PB, Brazil.ORCID 0000-0002-6987-262X
Maria Eugênia G de FreitasLaboratory of Biotechnology in Microorganisms, Biotechnology Center, Federal University of Paraíba (UFPB), João Pessoa 58051-900, PB, Brazil.
Ericke Cardoso OliveiraLaboratory of Cellular Biochemistry, Campus Centro-Oeste Dona Lindu, Federal University of São João Del-Rei, Divinópolis 35501-296, MG, Brazil.
Gustavo F de Frazao LimaLaboratory of Cellular Biochemistry, Campus Centro-Oeste Dona Lindu, Federal University of São João Del-Rei, Divinópolis 35501-296, MG, Brazil.
Demétrius A M de AraújoPostgraduate Program in Biotechnology (Renorbio), Federal University of Paraíba (UFPB), João Pessoa 58051-900, PB, Brazil.ORCID 0000-0001-7320-7203
Cristoforo ScavoneLaboratory of Neuropharmacology Research, Department of Pharmacology, Institute of Biomedical Sciences ICB-1, University of São Paulo, São Paulo 05508-900, SP, Brazil.ORCID 0000-0002-1206-0882
Thalisson Amorim de SouzaPostgraduate Program in Natural and Synthetic Bioactive Products, Department of Pharmaceutical Sciences, Federal University of Paraíba (UFPB), João Pessoa 58051-900, PB, Brazil.ORCID 0000-0002-6000-8747
José Augusto F P VillarLaboratory of Cellular Biochemistry, Campus Centro-Oeste Dona Lindu, Federal University of São João Del-Rei, Divinópolis 35501-296, MG, Brazil.ORCID 0000-0003-1580-0644
Leandro A BarbosaLaboratory of Cellular Biochemistry, Campus Centro-Oeste Dona Lindu, Federal University of São João Del-Rei, Divinópolis 35501-296, MG, Brazil.ORCID 0000-0002-4631-0130
Francisco Jaime Bezerra Mendonça-JuniorPostgraduate Program in Natural and Synthetic Bioactive Products, Department of Pharmaceutical Sciences, Federal University of Paraíba (UFPB), João Pessoa 58051-900, PB, Brazil.ORCID 0000-0003-3588-833X
Valnês S Rodrigues-JuniorPostgraduate Program in Natural and Synthetic Bioactive Products, Department of Pharmaceutical Sciences, Federal University of Paraíba (UFPB), João Pessoa 58051-900, PB, Brazil.ORCID 0000-0002-4849-2249
Sandra Rodrigues-MascarenhasLaboratory of Immunobiotechnology, Biotechnology Center, Federal University of Paraíba (UFPB), João Pessoa 58051-900, PB, Brazil.ORCID 0000-0003-4192-7382

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiotonic steroids modulate various aspects of the inflammatory response. The synthetic cardiotonic steroid γ-benzylidene digoxin 15 (BD-15), a digoxin derivative, has emerged as a promising candidate with potential immunomodulatory effects. However, its biological activity remains largely unexplored. This study investigated the anti-mycobacterial and anti-inflammatory effects of BD-15 in an in vitro macrophage infection model with

Indexed as

anti-inflammatorybenzylidene digoxindrug developmenthost-directed therapytberculosis

Identifiers

PMID40005637
PMCPMC11857721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.